BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9366526)

  • 1. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice.
    Zhang L; Kharbanda S; Chen D; Bullocks J; Miller DL; Ding IY; Hanfelt J; McLeskey SW; Kern FG
    Oncogene; 1997 Oct; 15(17):2093-108. PubMed ID: 9366526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L; Kharbanda S; Hanfelt J; Kern FG
    Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG
    Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.
    Kurebayashi J; McLeskey SW; Johnson MD; Lippman ME; Dickson RB; Kern FG
    Cancer Res; 1993 May; 53(9):2178-87. PubMed ID: 8481921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
    Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes.
    Zhang L; Kharbanda S; McLeskey SW; Kern FG
    Cancer Res; 1999 Oct; 59(19):5023-9. PubMed ID: 10519418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
    Arteaga CL; Carty-Dugger T; Moses HL; Hurd SD; Pietenpol JA
    Cell Growth Differ; 1993 Mar; 4(3):193-201. PubMed ID: 8466857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.
    Horii Y; Takei H; Koibuchi Y; Horiguchi J; Maemura M; Iino Y; Morishita Y
    Oncol Rep; 2006 May; 15(5):1191-5. PubMed ID: 16596185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis.
    McLeskey SW; Zhang L; Kharbanda S; Kurebayashi J; Lippman ME; Dickson RB; Kern FG
    Breast Cancer Res Treat; 1996; 39(1):103-17. PubMed ID: 8738610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
    Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
    Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
    Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
    Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
    Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
    Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.
    Weinstat-Saslow DL; Zabrenetzky VS; VanHoutte K; Frazier WA; Roberts DD; Steeg PS
    Cancer Res; 1994 Dec; 54(24):6504-11. PubMed ID: 7527299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
    Lu M; Miller KD; Gokmen-Polar Y; Jeng MH; Kinch MS
    Cancer Res; 2003 Jun; 63(12):3425-9. PubMed ID: 12810680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.